Crohn’s patients see 65% remission in clinical trial
November 18, 2021Business Services
Janssen has announced topline results from the Phase II GALAXI 1 clinical which showed rates of clinical remission previously reported …
NIAID and Children’s National Hospital begin long-term study of children with COVID-19
November 18, 2021Business Services
The National Institutes of Health has commenced a long-term investigation into the impacts of COVID-19 in children. The study, supported …
AstraZeneca COVID-19 antibody drug offers 83% protection over six month period
November 18, 2021Business Services
New data from AstraZeneca’s COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials have revealed high efficacy from a …
NICE recommends Opdivo (nivolumab) for oesophageal cancer treatment
November 17, 2021Research and Development
NICE has recommended nivolumab for the adjuvant treatment of completely resected oesophageal or gastro-oesophageal junction (GOJ) cancer, in adults who …
Health experts warn of a ‘hidden pandemic’ of antibiotic-resistant infections
November 17, 2021Research and Development
UK health officials have warned that a ‘hidden pandemic’ of antibiotic-resistant infections could occur if people take antibiotics to fight …
Pfizer deal allows generic versions of COVID pill for low-income countries
November 17, 2021Research and Development
Pfizer has announced a deal for the production of its antiviral Paxlovid pill to generic drug manufactures, for supply in …
US secures over 750,000 doses of GSK-Vir COVID-19 drug
November 17, 2021Research and Development
The US has secured GSK and Vir Biotechnology’s antibody-based COVID-19 treatment, through signing contracts worth approximately $1 billion, according to …
Orexo’s new drug effective against opioid overdoses
November 16, 2021Manufacturing and Production
Orexo announced it has successfully completed the trial for its lead pharmaceutical pipeline asset, OX124, designed to help patients in …
Moderna announce promising study in mRNA drug for heart failure
November 16, 2021Manufacturing and Production
The biotechnology company Moderna have announced positive data from the AstraZeneca-led Phase IIa EPICCURE trial, evaluating the use of a …
Revelar Biotherapeutics launches for development of COVID-19 and other antibody therapeutics
November 16, 2021Manufacturing and Production
Twist Bioscience Corporation announced that it has launched Revelar Biotherapeutics, an independently operated, new biotechnology company to develop and commercialise …
Arrowhead Collaboration presents Phase IIb data from Hepatitis B study
November 16, 2021Manufacturing and Production
Arrowhead Pharmaceuticals Inc collaborator, Janssen Pharmaceuticals Inc, have presented clinical data from REEF-1, a Phase IIb study of different combination …
Emergex trial new form of COVID vaccine
November 15, 2021Sales and Marketing
Emergex, an Oxfordshire based company, is moving towards Phase I trials for its novel COVID-19 vaccine, which is applied as …
Theramex launches Femarelle to treat menopause symptoms
November 15, 2021Sales and Marketing
Theramex recently announced that they have acquired the Femarelle ® product licence to treat menopause symptoms. The commercialisation agreement was reached …
Pfizer vaccine generates most antibodies, comparative study suggests
November 15, 2021Sales and Marketing
Pfizer Inc. and BioNTech’s COVID-19 vaccine yielded the strongest immune response in a comparative study of four vaccines. The study, …
First patient dosed in tumour membrane immunotherapy trial
November 15, 2021Sales and Marketing
Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumour membrane immunotherapy, announced that …
Biogen’s Aduhelm shown to reduce clinical decline in Alzheimer’s disease
November 12, 2021Medical Communications
New ADUHELM (aducanumab-avwa) Phase III data has shown a positive correlation between plasma p-tau reduction and less cognitive and functional …
Blood pressure drugs could protect against type 2 diabetes
November 12, 2021Medical Communications
Researchers have found that blood pressure drugs may directly reduce people’s risk of type 2 diabetes, a condition that an …
Trial investigates whether immunosuppressant holiday boosts vaccine protection
November 12, 2021Medical Communications
A trial has been launched to evaluate how to increase COVID-19 vaccine protection among vulnerable patients taking immunosuppressant drugs . …
Kintor Pharma begins Phase II trial of KX-826 for androgenetic alopecia treatment
November 12, 2021Medical Communications
Kintor Pharma, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the …
New experimental drug identified for pancreatic cancer treatment
November 11, 2021Business Services
Professor Shudong Wang, Head of Drug Discovery and Development at the University of South Australia, is hoping to utilise the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
